166 related articles for article (PubMed ID: 15650263)
1. Secretory leukocyte protease inhibitor in cancer development.
Devoogdt N; Revets H; Ghassabeh GH; De Baetselier P
Ann N Y Acad Sci; 2004 Dec; 1028():380-9. PubMed ID: 15650263
[TBL] [Abstract][Full Text] [Related]
2. Secretory leukocyte protease inhibitor promotes the tumorigenic and metastatic potential of cancer cells.
Devoogdt N; Hassanzadeh Ghassabeh G; Zhang J; Brys L; De Baetselier P; Revets H
Proc Natl Acad Sci U S A; 2003 May; 100(10):5778-82. PubMed ID: 12732717
[TBL] [Abstract][Full Text] [Related]
3. Up-regulation of secretory leukocyte protease inhibitor (SLPI) in the brain after ischemic stroke: adenoviral expression of SLPI protects brain from ischemic injury.
Wang X; Li X; Xu L; Zhan Y; Yaish-Ohad S; Erhardt JA; Barone FC; Feuerstein GZ
Mol Pharmacol; 2003 Oct; 64(4):833-40. PubMed ID: 14500739
[TBL] [Abstract][Full Text] [Related]
4. The secretory leukocyte protease inhibitor is a type 1 insulin-like growth factor receptor-regulated protein that protects against liver metastasis by attenuating the host proinflammatory response.
Wang N; Thuraisingam T; Fallavollita L; Ding A; Radzioch D; Brodt P
Cancer Res; 2006 Mar; 66(6):3062-70. PubMed ID: 16540655
[TBL] [Abstract][Full Text] [Related]
5. The secretory leukoprotease inhibitor (SLPI) promoter for ovarian cancer gene therapy.
Barker SD; Coolidge CJ; Kanerva A; Hakkarainen T; Yamamoto M; Liu B; Rivera AA; Bhoola SM; Barnes MN; Alvarez RD; Curiel DT; Hemminki A
J Gene Med; 2003 Apr; 5(4):300-10. PubMed ID: 12692864
[TBL] [Abstract][Full Text] [Related]
6. Secretory leukocyte peptidase inhibitor and lung cancer.
Nukiwa T; Suzuki T; Fukuhara T; Kikuchi T
Cancer Sci; 2008 May; 99(5):849-55. PubMed ID: 18380788
[TBL] [Abstract][Full Text] [Related]
7. The cloning and characterization of a murine secretory leukocyte protease inhibitor cDNA.
Zitnik RJ; Zhang J; Kashem MA; Kohno T; Lyons DE; Wright CD; Rosen E; Goldberg I; Hayday AC
Biochem Biophys Res Commun; 1997 Mar; 232(3):687-97. PubMed ID: 9126337
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of murine neutrophil serine proteinases by human and murine secretory leukocyte protease inhibitor.
Wright CD; Kennedy JA; Zitnik RJ; Kashem MA
Biochem Biophys Res Commun; 1999 Jan; 254(3):614-7. PubMed ID: 9920787
[TBL] [Abstract][Full Text] [Related]
9. Secretory leukocyte protease inhibitor mediates non-redundant functions necessary for normal wound healing.
Ashcroft GS; Lei K; Jin W; Longenecker G; Kulkarni AB; Greenwell-Wild T; Hale-Donze H; McGrady G; Song XY; Wahl SM
Nat Med; 2000 Oct; 6(10):1147-53. PubMed ID: 11017147
[TBL] [Abstract][Full Text] [Related]
10. Helicobacter pylori-induced downregulation of the secretory leukocyte protease inhibitor (SLPI) in gastric epithelial cell lines and its functional relevance for H. pylori-mediated diseases.
Wex T; Treiber G; Venerito M; Leodolter A; Peitz U; Kuester D; Hritz I; Krueger S; Roessner A; Malfertheiner P
Biol Chem; 2006 Jul; 387(7):893-901. PubMed ID: 16913839
[TBL] [Abstract][Full Text] [Related]
11. Secretory leukoprotease inhibitor inhibits cell growth through apoptotic pathway on ovarian cancer.
Nakamura K; Takamoto N; Hongo A; Kodama J; Abrzua F; Nasu Y; Kumon H; Hiramatsu Y
Oncol Rep; 2008 May; 19(5):1085-91. PubMed ID: 18425362
[TBL] [Abstract][Full Text] [Related]
12. Secretory leucocyte protease inhibitor in the male genital tract: PSA-induced proteolytic processing in human semen and tissue localization.
Ohlsson K; Bjartell A; Lilja H
J Androl; 1995; 16(1):64-74. PubMed ID: 7539415
[TBL] [Abstract][Full Text] [Related]
13. In silico study of whey-acidic-protein domain containing oral protease inhibitors.
Idoji Y; Watanabe Y; Yamashita A; Yamanishi K; Nishiguchi S; Shimada K; Yasunaga T; Yamanishi H
Int J Mol Med; 2008 Apr; 21(4):461-8. PubMed ID: 18360692
[TBL] [Abstract][Full Text] [Related]
14. Characterization of secretory leukocyte protease inhibitor as an inhibitor of implantation serine proteinases.
Sharma N; Kaur J; Xu H; Zur Nieden N; Rancourt D
Mol Reprod Dev; 2008 Jul; 75(7):1136-42. PubMed ID: 18163438
[TBL] [Abstract][Full Text] [Related]
15. Secretory leukocyte protease inhibitor is a novel inhibitor of fibroblast-mediated collagen gel contraction.
Sumi Y; Muramatsu H; Hata K; Ueda M; Muramatsu T
Exp Cell Res; 2000 Apr; 256(1):203-12. PubMed ID: 10739667
[TBL] [Abstract][Full Text] [Related]
16. Mitosis increases levels of secretory leukocyte protease inhibitor in keratinocytes.
Lai JY; Borson ND; Strausbauch MA; Pittelkow MR
Biochem Biophys Res Commun; 2004 Apr; 316(2):407-10. PubMed ID: 15020232
[TBL] [Abstract][Full Text] [Related]
17. Attenuated induction of epithelial and leukocyte serine antiproteases elafin and secretory leukocyte protease inhibitor in Crohn's disease.
Schmid M; Fellermann K; Fritz P; Wiedow O; Stange EF; Wehkamp J
J Leukoc Biol; 2007 Apr; 81(4):907-15. PubMed ID: 17200145
[TBL] [Abstract][Full Text] [Related]
18. Multifaceted roles of human elafin and secretory leukocyte proteinase inhibitor (SLPI), two serine protease inhibitors of the chelonianin family.
Moreau T; Baranger K; Dadé S; Dallet-Choisy S; Guyot N; Zani ML
Biochimie; 2008 Feb; 90(2):284-95. PubMed ID: 17964057
[TBL] [Abstract][Full Text] [Related]
19. Identification of SLPI (secretory leukocyte protease inhibitor) in human mast cells using immunohistochemistry and in situ hybridisation.
Westin U; Polling A; Ljungkrantz I; Ohlsson K
Biol Chem; 1999 Apr; 380(4):489-93. PubMed ID: 10355635
[TBL] [Abstract][Full Text] [Related]
20. Effect of toll-like receptor (TLR) agonists on TLR and microbicide expression in uterine and vaginal tissues of the mouse.
Soboll G; Schaefer TM; Wira CR
Am J Reprod Immunol; 2006 Jun; 55(6):434-46. PubMed ID: 16674601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]